{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:20:50Z","timestamp":1793118050564,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.vaccine.2020.11.071","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T04:38:51Z","timestamp":1610512731000},"page":"1007-1017","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["A plasmid encoding the extracellular domain of CD40 ligand and Montanide\u2122 GEL01 as adjuvants enhance the immunogenicity and the protection induced by a DNA vaccine against BoHV-1"],"prefix":"10.1016","volume":"39","author":[{"given":"Claudia Alejandra","family":"Kornuta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia Ana","family":"Langellotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Esteban","family":"Bidart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Soria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Quattrocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariela","family":"Gammella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Cheuquep\u00e1n Valenzuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Clara","family":"Mignaqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Ferraris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Charleston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanina Paola","family":"Hecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dadin Prando","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia In\u00e9s","family":"Zamorano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.11.071_b0005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1017\/S1466252309990028","article-title":"Bovine herpes virus infections in cattle","volume":"10","author":"Nandi","year":"2009","journal-title":"Anim Health Res Rev"},{"key":"10.1016\/j.vaccine.2020.11.071_b0010","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/01652176.2013.799301","article-title":"Bovine herpesvirus-1 (BHV-1) \u2013 a re-emerging concern in livestock: a revisit to its biology, epidemiology, diagnosis, and prophylaxis","volume":"33","author":"Biswas","year":"2013","journal-title":"Vet Quart"},{"key":"10.1016\/j.vaccine.2020.11.071_b0015","first-page":"303","article-title":"Bovine Herpesvirus Type 1 (BHV-1) is an important cofactor in the bovine respiratory disease complex","volume":"26","author":"Jones","year":"2010","journal-title":"Vet Clin North Am: Food Anim Pract"},{"key":"10.1016\/j.vaccine.2020.11.071_b0020","doi-asserted-by":"crossref","unstructured":"White DW, Suzanne Beard R, Barton ES. Immune modulation during latent herpesvirus infection. Immunol Rev 2012; 245:189\u2013208. https:\/\/doi.org\/10.1111\/j.1600-065X.2011.01074.x.","DOI":"10.1111\/j.1600-065X.2011.01074.x"},{"key":"10.1016\/j.vaccine.2020.11.071_b0025","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1128\/CMR.16.1.79-95.2003","article-title":"Herpes simplex virus Type 1 and bovine herpesvirus 1 latency","volume":"16","author":"Jones","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2020.11.071_b0030","doi-asserted-by":"crossref","unstructured":"Kornuta CA, Bidart JE, Soria I, Gammella M, Quattrocchi V, Pappalardo JS, et al. MAN\u03b11\u20102MAN decorated liposomes enhance the immunogenicity induced by a DNA vaccine against BoHV\u20101. Transbound Emerg Dis 2020:tbed.13718. https:\/\/doi.org\/10.1111\/tbed.13718.","DOI":"10.1111\/tbed.13718"},{"key":"10.1016\/j.vaccine.2020.11.071_b0035","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.antiviral.2011.03.185","article-title":"Induction of specific cytotoxic activity for bovine herpesvirus-1 by DNA immunization with different adjuvants","volume":"90","author":"Langellotti","year":"2011","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2020.11.071_b0040","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1146\/annurev.immunol.15.1.617","article-title":"DNA vaccines","volume":"15","author":"Donnelly","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2020.11.071_b0045","unstructured":"Ruiz-Saenz J, Jairo Jaime, V\u00edctor Vera, VACUNAS CONTRA EL HERPESVIRUS BOVINO-1: UNA MIRADA DESDE EL PASADO HACIA EL FUTURO DE LA INMUNIZACI\u00d3N Bovine Herpesvirus-1 vaccine\u2019s: A look from the past to the immunization future. vol. 14; 2009."},{"key":"10.1016\/j.vaccine.2020.11.071_b0050","doi-asserted-by":"crossref","unstructured":"Quattrocchi V, Soria I, Langellotti CA, Gnazzo V, Gammella M, Moore DP, et al. A DNA vaccine formulated with chemical adjuvant provides partial protection against bovine herpes virus infection in cattle. Front Immunol 2017; 8. https:\/\/doi.org\/10.3389\/fimmu.2017.00037.","DOI":"10.3389\/fimmu.2017.00037"},{"key":"10.1016\/j.vaccine.2020.11.071_b0055","doi-asserted-by":"crossref","DOI":"10.1186\/s13567-014-0111-x","article-title":"Bovine herpesvirus glycoprotein D: a review of its structural characteristics and applications in vaccinology","volume":"45","author":"Alves Dummer","year":"2014","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2020.11.071_b0060","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0264-410X(02)00574-1","article-title":"Induction of immune responses by DNA vaccines in large animals","volume":"21","author":"Babiuk","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.071_b0065","doi-asserted-by":"crossref","unstructured":"Gurunathan S, Klinman DM, Seder RA. DNA VACCINES: Immunology, Application, and Optimization*. vol. 18. 2000.","DOI":"10.1146\/annurev.immunol.18.1.927"},{"key":"10.1016\/j.vaccine.2020.11.071_b0070","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1128\/JVI.72.7.5648-5653.1998","article-title":"Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA","volume":"72","author":"Ulmer","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.11.071_b0075","doi-asserted-by":"crossref","first-page":"10214","DOI":"10.1128\/JVI.73.12.10214-10223.1999","article-title":"Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response","volume":"73","author":"Lewis","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.11.071_b0080","doi-asserted-by":"crossref","unstructured":"Lewis PJ, Cox GJM, Littel-Van Den Hurk S van D, Babiuk LA. Polynucleotide vaccines in animals: Enhancing and modulating responses. Vaccine 1997; 15:861\u20134. https:\/\/doi.org\/10.1016\/S0264-410X(96)00279-4.","DOI":"10.1016\/S0264-410X(96)00279-4"},{"key":"10.1016\/j.vaccine.2020.11.071_b0085","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1089\/vim.2014.0113","article-title":"Use of Adjuvants to enhance the immune response induced by a DNA vaccine against bovine herpesvirus-1","volume":"28","author":"Di Giacomo","year":"2015","journal-title":"Viral Immunol"},{"issue":"1-2","key":"10.1016\/j.vaccine.2020.11.071_b0090","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.vetpar.2015.03.012","article-title":"Immunogenicity and protective efficacy of an Eimeria vaccine candidate based on Eimeria tenella immune mapped protein 1 and chicken CD40 ligand","volume":"210","author":"Yin","year":"2015","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2020.11.071_b0095","doi-asserted-by":"crossref","unstructured":"Elgueta R, Benson MJ, De Vries VC, Wasiuk A, Guo Y, Noelle RJ. Molecular mechanism and function of CD40\/CD40L engagement in the immune system. Immunol Rev 2009; 229:152\u201372. https:\/\/doi.org\/10.1111\/j.1600-065X.2009.00782.x.","DOI":"10.1111\/j.1600-065X.2009.00782.x"},{"key":"10.1016\/j.vaccine.2020.11.071_b0100","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.imlet.2008.12.010","article-title":"Hypoxia influences CD40\u2013CD40L mediated inflammation in endothelial and monocytic cells","volume":"122","author":"Chakrabarti","year":"2009","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2020.11.071_b0105","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.provac.2010.03.003","article-title":"Microgel particulate adjuvant: characterisation and mechanisms of action","volume":"2","author":"Vialle","year":"2010","journal-title":"Procedia in Vaccinology"},{"key":"10.1016\/j.vaccine.2020.11.071_b0110","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.vaccine.2011.12.110","article-title":"CD205 antigen targeting combined with dendritic cell recruitment factors and antigen-linked CD40L activation primes and expands significant antigen-specific antibody and CD4+ T cell responses following DNA vaccination of outbred animals","volume":"30","author":"Njongmeta","year":"2012","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2020.11.071_b0115","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1128\/CVI.00178-06","article-title":"Characterization of a phenotypically unique population of CD13+ dendritic cells resident in the spleen","volume":"13","author":"Zhuang","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2020.11.071_b0120","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/nprot.2006.125","article-title":"Isolation and purification of afferent lymph dendritic cells that drain the skin of cattle","volume":"1","author":"Hope","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.vaccine.2020.11.071_b0125","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifthy percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2020.11.071_b0130","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1128\/CVI.00034-14","article-title":"Comparison of test methodologies for foot-and-mouth disease virus serotype A vaccine matching","volume":"21","author":"Tekleghiorghis","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2020.11.071_b0135","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0264-410X(00)00104-3","article-title":"Adjuvant effects of sulfolipo-cyclodextrin in a squalane-in-water and water-in-mineral oil emulsions for BHV-1 vaccines in cattle","volume":"19","author":"Romera","year":"2000","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.vaccine.2020.11.071_b0140","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.vaccine.2014.02.061","article-title":"Early protection against foot-and-mouth disease virus in cattle using an inactivated vaccine formulated with Montanide ESSAI IMS D 12802 VG PR adjuvant","volume":"32","author":"Quattrocchi","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.071_b0145","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1746-6148-10-8","article-title":"Protection induced by a glycoprotein E-deleted bovine herpesvirus type 1 marker strain used either as an inactivated or live attenuated vaccine in cattle","volume":"10","author":"Romera","year":"2014","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.vaccine.2020.11.071_b0150","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1128\/JVI.72.5.3812-3818.1998","article-title":"Dendritic cells efficiently induce protective antiviral immunity","volume":"72","author":"Ludewig","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.11.071_b0155","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0952-7915(02)00365-5","article-title":"How dendritic cells and microbes interact to elicit or subvert protective immune responses","volume":"14","author":"Palucka","year":"2002","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2020.11.071_b0160","doi-asserted-by":"crossref","unstructured":"Jones C. Bovine herpesvirus 1 counteracts immune responses and immune-surveillance to enhance pathogenesis and virus transmission. Front Immunol 2019;10. https:\/\/doi.org\/10.3389\/fimmu.2019.01008.","DOI":"10.3389\/fimmu.2019.01008"},{"issue":"2","key":"10.1016\/j.vaccine.2020.11.071_b0165","doi-asserted-by":"crossref","first-page":"989","DOI":"10.4049\/jimmunol.170.2.989","article-title":"Targeting with Bovine CD154 enhances humoral immune responses induced by a DNA vaccine in sheep","volume":"170","author":"Manoj","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.11.071_b0170","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0378-1135(96)01232-1","article-title":"Immunology of bovine herpesvirus 1 infection","volume":"53","author":"Babiuk","year":"1996","journal-title":"Vet Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2020.11.071_b0175","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1046\/j.1365-2567.2000.00962.x","article-title":"Activation of bovine B cells via surface immunoglobulin M cross-linking or CD40 ligation results in different B-cell phenotypes","volume":"99","author":"Haas","year":"2000","journal-title":"Immunology"},{"issue":"11","key":"10.1016\/j.vaccine.2020.11.071_b0180","doi-asserted-by":"crossref","first-page":"5913","DOI":"10.4049\/jimmunol.164.11.5913","article-title":"CD40 Ligand (CD154) enhances the Th1 and antibody responses to respiratory syncytial virus in the BALB\/c Mouse","volume":"164","author":"Tripp","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.11.071_b0185","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1365-2567.2004.01877.x","article-title":"Modulation of immune responses to bovine herpesvirus-1 in cattle by immunization with a DNA vaccine encoding glycoprotein D as a fusion protein with bovine CD154","volume":"112","author":"Manoj","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2020.11.071_b0190","doi-asserted-by":"crossref","unstructured":"Langellotti CA, Gammella M, Soria I, Bellusci C, Quattrocchi V, Vermeulen M, et al. An improved DNA vaccine against bovine Herpesvirus-1 using CD40L and a chemical adjuvant induces specific cytotoxicity in mice. Viral Immunol 2020:vim.2020.0082. https:\/\/doi.org\/10.1089\/vim.2020.0082.","DOI":"10.1089\/vim.2020.0082"},{"key":"10.1016\/j.vaccine.2020.11.071_b0195","article-title":"A trial for preparationand assessment of montanide gel 01 adjuvanted inactivated strangles vaccine","author":"Abd El-Twaab","year":"2019","journal-title":"Biosci Res"},{"key":"10.1016\/j.vaccine.2020.11.071_b0200","doi-asserted-by":"crossref","unstructured":"Alfaro C, O\u00f1ate C, Rodr\u00edguez A, P\u00e9rez-Gracia JL, de Sanmamed MF, Melero I. C\u00e9lulas dendr\u00edticas especializadas en presentaci\u00f3n de ant\u00edgenos ex\u00f3genos a linfocitos T citot\u00f3xicos. An Sist Sanit Navar 2013;36:519\u201337. https:\/\/doi.org\/10.4321\/S1137-66272013000300016.","DOI":"10.4321\/S1137-66272013000300016"},{"key":"10.1016\/j.vaccine.2020.11.071_b0205","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/85251","article-title":"The expanding B7 superfamily: Increasing complexity in costimulatory signals regulating T cell function","volume":"2","author":"Coyle","year":"2001","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2020.11.071_b0210","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.4049\/jimmunol.178.5.2844","article-title":"CD40-CD40 ligand interaction between dendritic cells and CD8 + T cells is needed to stimulate maximal T cell responses in the absence of CD4 + T cell help","volume":"178","author":"Hernandez","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.11.071_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-2427(02)00201-5","article-title":"Type 1 and type 2 responses in regulation of Ig isotype expression in cattle","volume":"90","author":"Estes","year":"2002","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2020.11.071_b0220","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0008-8749(89)90193-7","article-title":"Role of interferon-\u03b3 in inducing cytotoxicity of peripheral blood mononuclear leukocytes to bovine herpesvirus type 1 (BHV-1)-infected cells","volume":"120","author":"Campos","year":"1989","journal-title":"Cell Immunol"},{"key":"10.1016\/j.vaccine.2020.11.071_b0225","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/rheumatology\/keq031","article-title":"Review Transmembrane TNF-a: structure, function and interaction with anti-TNF agents","volume":"49","author":"Horiuchi","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.vaccine.2020.11.071_b0230","series-title":"inflamm Allergy Drug Des","first-page":"225","article-title":"Tumor necrosis factor alpha","author":"Brightling","year":"2011"},{"key":"10.1016\/j.vaccine.2020.11.071_b0235","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.rvsc.2006.01.004","article-title":"BHV-1 vaccine induces cross-protection against BHV-5 disease in cattle","volume":"81","author":"Del M\u00e9dico Zajac","year":"2006","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2020.11.071_b0240","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0264-410X(99)00536-8","article-title":"A gE-negative bovine herpesvirus 1 vaccine strain is not re-excreted nor transmitted in an experimental cattle population after corticosteroid treatments","volume":"18","author":"Mars","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.071_b0245","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0165-2427(94)05363-W","article-title":"Isotype-specific antibody responses in sera and mucosal secretions of calves experimentally infected with bovine herpesvirus 1","volume":"46","author":"Madic","year":"1995","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2020.11.071_b0250","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0165-2427(94)05379-7","article-title":"Isotype-specific antibody responses to bovine herpesvirus 1 in sera and mucosal secretions of calves after experimental reinfection and after reactivation","volume":"47","author":"Madic","year":"1995","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2020.11.071_b0255","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/S0264-410X(00)00556-9","article-title":"Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity","volume":"19","author":"Haan","year":"2001","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2031553X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2031553X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:53:36Z","timestamp":1759402416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2031553X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0264410X2031553X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.11.071","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A plasmid encoding the extracellular domain of CD40 ligand and Montanide\u2122 GEL01 as adjuvants enhance the immunogenicity and the protection induced by a DNA vaccine against BoHV-1","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.11.071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}